COMMUNIQUÉS West-GlobeNewswire

Major shareholder announcement - BlackRock, Inc.
28/10/2026
ANNOUNCEMENT NO. 323 28 October 2026 Pursuant to section 30 of the Danish Capital Markets Act, notice is hereby given that BlackRock, Inc. has notified ChemoMetec A/S that, on 26 October 2026, BlackRock, Inc. increased [...]
Chiffre d’affaires au Septembre 2026
28/10/2026
Le chiffre d’affaires à fin septembre 2026 s’établit à €4 051m , en progression de +4,7% en base organique par rapport à la même période de 2025 L’ensemble des activités et des régions contribue à la croissance du [...]
Revenue for the nine months ended September 2026
28/10/2026
Revenue at end September 2026 of €4,051m, up +4.7% on an organic basis compared with the same period in 2025 All activities and regions contributed to revenue growth, supported by favourable volume, price and case mix [...]
Nordic Naturals Joins Eudēmonia Summit as Featured Partner and Exhibitor, Hosting Panel on Omega-3s and Healthy Aging
28/10/2026
Watsonville, CA, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Nordic Naturals , the #1 selling omega-3 brand in the U.S.‡, today announced it will be a featured partner and brand presenter at the Eudēmonia Summit, a science-based [...]
Mesa Labs Announces Second Quarter Financial Results Release Date and Earnings Conference Call
28/10/2026
Lakewood, Colo., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”), a global leader in the design and manufacture of critical quality control solutions and [...]
Kymera Therapeutics to Announce KT-579 Phase 1 Healthy Volunteer Trial Results on October 29, 2026
28/10/2026
WATERTOWN, Mass., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological [...]
MIMEDX Announces $25 Million Patent License Agreement
28/10/2026
MARIETTA, Ga., Oct. 28, 2026 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that it has entered into a license agreement with a wound care competitor that resolves [...]
ARS Pharma to Report Third Quarter 2026 Financial Results
28/10/2026
SAN DIEGO, Oct. 28, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a commercial biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from [...]
Adial Pharmaceuticals Announces Name Change to Azora Therapeutics and New Executive Team, Focused on Advancing AT177, an Oral, Colon-Targeted AhR Agonist for Ulcerative Colitis
28/10/2026
Stockholders approved the conversion of the preferred stock issued in the June 2026 acquisition of Azora Therapeutics Azora’s common stock to begin trading on Nasdaq under the ticker symbol “AZR” New executive [...]
MIMEDX Announces Third Quarter 2026 Operating & Financial Results
28/10/2026
Reports Continued Double-Digit Year-Over-Year Volume Growth for Surgical Franchise Delivers Wound Care Center Volume Growth Both Sequentially and Year-Over-Year Obtained Favorable Federal Court Ruling in AXIOFILL ® [...]
Coherus Oncology Announces Compelling Tagmokitug Interim Clinical Data in Esophageal Cancer and Path to Advance Development
28/10/2026
- 1L ESCC confirmed ORR of 75% irrespective of PD-L1 status, confirmed ORR of 100% for PD-L1- positive, in evaluable patients- -2L ESCC durable clinical benefit observed with a clear dose-response irrespective of PD-L1 [...]
Ceribell to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
28/10/2026
SUNNYVALE, Calif., Oct. 28, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological [...]
Pasithea Therapeutics to Host Virtual KOL Event on NF1 Treatment November 4, 2026
28/10/2026
Rebecca M. Brown, MD, and Kavita Sarin, MD, PhD, will join management to discuss unmet needs and the treatment landscape for NF1-associated cutaneous and plexiform neurofibromas MIAMI, Oct. 28, 2026 (GLOBE NEWSWIRE) -- [...]
Teladoc Health Reports Third Quarter 2026 Results
28/10/2026
NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today reported financial results for the three months ended September 30, 2026 (“Third Quarter 2026”). [...]
Emory Researchers Identify Blood Protein Signature That Detects ALS With 98% Accuracy Using Alamar Technology
28/10/2026
Published in Nature Communications, the study found a 10-protein signature that outperformed a leading individual ALS biomarker, including in some patients with difficult-to-diagnose presentations Fremont, Calif., Oct. [...]
Jushi Holdings Inc. Reports Third Quarter 2026 Financial Results
28/10/2026
Revenue Increased 7% Year-over-Year to $70.5 Million, With Growth Across Wholesale and Retail Channels Wholesale Revenue Increased 40% Year-Over-Year to $9.7 Million, Setting Second Consecutive Quarterly Record Virginia [...]
Mineralys Therapeutics to Announce Third Quarter 2026 Financial Results and Host Conference Call on Wednesday, November 4, 2026
28/10/2026
RADNOR, Pa., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and aldosterone-related adverse outcomes in [...]
BayCare Selected as a National Best Workplace for Women
28/10/2026
CLEARWATER, Fla., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Great Place to Work® and Fortune magazine have selected BayCare for the 2026 Fortune Best Workplaces for Women™ list, marking the sixth time BayCare has earned a spot [...]
NVision Unveils First Manufacturable Molecular Qubit, Breakthrough Validated in Peer-Reviewed Nature Paper
28/10/2026
Partners with HyperLight to integrate thin-film molecular qubits onto advanced photonic integrated circuits, paving the way for a new architecture that delivers quantum computing at scale NVision Unveils First [...]

Pages

Other news

Test 2

22/10/2026

Lorem ipsum

Test 1

22/10/2026

Lorem upsum